Register entry
- Registered sites
- 0
- Active NDC listings
- 9
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
99 active NDC listings: 9 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 9.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 9 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| pfizer italia s.r.l. | 9 |
Catalogue
Marketed products
9| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | ELETRIPTAN HYDROBROMIDE | tablet, film coated | 10829-0557DRUG FOR FURTHER PROCESSING |
| - | ELETRIPTAN HYDROBROMIDE | tablet, film coated | 10829-0558DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 10829-0008DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 10829-0025DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 10829-0055DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 10829-0145DRUG FOR FURTHER PROCESSING |
| - | orforglipron | tablet, film coated | 10829-0172DRUG FOR FURTHER PROCESSING |
| - | varenicline tartrate | tablet, film coated | 10829-1468DRUG FOR FURTHER PROCESSING |
| - | varenicline tartrate | tablet, film coated | 10829-1469DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing orforglipron
- Eli Lilly and Company10 sites · 189 NDC
- Lilly del Caribe, Inc.0 sites · 46 NDC
Enquiry
Common questions
- Is Pfizer Italia S.r.l. FDA approved?
- Pfizer Italia S.r.l. holds no registered establishment of its own; 9 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Pfizer Italia S.r.l. make?
- 9 products are listed under Pfizer Italia S.r.l. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.